Home › Depression › North Carolina › Charlotte
Depression clinical trials in Charlotte, NC
3 studies for Depression are looking for participants at sites in and around Charlotte (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
NBI-1065845-MDD3026: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
RecruitingPhase 3
- Neurocrine Clinical Site, Charlotte
E-Mindfulness Approaches for Living After Breast Cancer
RecruitingPhase 3
- Carolinas Medical Center/Levine Cancer Institute, Charlotte
- Atrium Health Pineville/LCI-Pineville, Charlotte
- Levine Cancer Institute-SouthPark, Charlotte
- and 7 more
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
RecruitingPhase 3
- New Hope Clinical Research, Charlotte
About Depression
Depression is a serious medical illness. It affects almost 7 percent of U.S. adults. It causes feelings of sadness, hopelessness, and frustration that do not go away. Learn about treatments.
More about Depression on MedlinePlus
Depression trials in other cities
- Boston, MA52 studies
- New York City, NY45 studies
- Philadelphia, PA26 studies
- Atlanta, GA24 studies
- Chicago, IL24 studies
- Pittsburgh, PA22 studies
- San Diego, CA21 studies
- Charleston, SC19 studies
- Houston, TX18 studies
- Orlando, FL17 studies
- Los Angeles, CA17 studies
- Miami, FL16 studies
Other studies in Charlotte
- Cancer (all types)27 studies
- Breast Cancer22 studies
- Multiple Myeloma21 studies
- Non-Small Cell Lung Cancer19 studies
- Acute Myeloid Leukemia16 studies
- Obesity16 studies
- Overweight15 studies
- Colorectal Cancer13 studies
- Ovarian Cancer12 studies
- Metastatic Cancer11 studies
- Heart Failure11 studies
- Head and Neck Squamous Cell Carcinoma10 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.